Axogen (AXGN) Operating Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,543.00 |
| Dec 31, 2025 | 23.00 |
| Sep 30, 2025 | 631.00 |
| Jun 30, 2025 | 4,027.00 |
| Mar 31, 2025 | 3,165.00 |
| Dec 31, 2024 | 3,043.00 |
| Sep 30, 2024 | 2,075.00 |
| Jun 30, 2024 | 2,784.00 |
| Mar 31, 2024 | 3,280.00 |
| Dec 31, 2023 | 1,754.00 |
| Sep 30, 2023 | 1,158.00 |
| Jun 30, 2023 | 532.00 |
| Mar 31, 2023 | 889.00 |
| Dec 31, 2022 | -486.00 |
| Sep 30, 2022 | -380.00 |
| Jun 30, 2022 | -1,347.00 |
| Mar 31, 2022 | -1,036.00 |
| Dec 31, 2021 | 686.00 |
| Sep 30, 2021 | -1,089.00 |
| Jun 30, 2021 | -584.00 |
| Mar 31, 2021 | 1,229.00 |
| Dec 31, 2020 | 1,742.00 |
| Sep 30, 2020 | 2,039.00 |
| Jun 30, 2020 | -377.00 |
| Mar 31, 2020 | 1,630.00 |
| Dec 31, 2019 | 3,017.00 |
| Sep 30, 2019 | 1,720.00 |
| Jun 30, 2019 | 2,579.00 |
| Mar 31, 2019 | 5,149.00 |
| Dec 31, 2018 | 6,874.00 |
| Sep 30, 2018 | 5,565.00 |
| Jun 30, 2018 | 5,326.00 |
| Mar 31, 2018 | 7,951.00 |
| Dec 31, 2017 | 9,846.00 |
| Sep 30, 2017 | 9,380.00 |
| Jun 30, 2017 | 6,932.00 |
| Mar 31, 2017 | 9,125.00 |
| Dec 31, 2016 | 12,224.00 |
| Sep 30, 2016 | 21,969.00 |
| Jun 30, 2016 | 10,295.00 |
| Mar 31, 2016 | 4,809.00 |
| Dec 31, 2015 | 14,516.00 |
| Sep 30, 2015 | 8,623.00 |
| Jun 30, 2015 | 1.04 Mn |